Knight Therapeutics | Les Charges D'Exploitation



Operating Expenses Changement Date
Acasti Pharma USD 52.14M 47.31M 2024-12
Alaunos Therapeutics USD 1.15M 20K 2024-09
Aurora Cannabis CAD 51.98M 31.53M 2024-12
Avita Medical AUD 28.36M 2.44M 2024-12
Canopy Growth CAD 98.58M 10.03M 2024-12
Cronos Group USD 41.67M 4.42M 2024-12
Dianthus Therapeutics USD 32.07M 8M 2024-09
Ionis Pharmaceuticals USD 337.4M 54.93M 2024-12
IQVIA Holdings USD 3.33B 14M 2024-12
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Moderna USD 2.21B 280M 2024-12
Organigram Holdings CAD 54.04M 9.62M 2024-12
Organon & Co USD 1.46B 88M 2024-12
Revvity USD 610.62M 24.72M 2024-12
Tectonic Therapeutic USD 19.64M 8.22M 2024-09
Tilray USD 253.17M 16.55M 2024-11
Viatris USD 3.55B 84.2M 2024-12
Xeris Pharmaceuticals USD 67.16M 10.91M 2024-09



Knight Therapeutics Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.